To celebrate Ophthalmology Times' 50th anniversary, we asked leading experts what the practice would look like today had ...

Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry AMD ...

ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY ( NCT06659445) trial evaluating ...

Oluwatosin U. Smith, MD, reflects on early experiences caring for pediatric patients with complex glaucoma and how evolving ...

The BIM-IOL system showed a 42% reduction in mean IOP and improved visual acuity, with no serious adverse events linked to ...

Andrew G. Lee, MD, was joined by Drew Carey, MD, for a live recording of the Ophthalmology Times “NeuroOp Guru” during the ...

Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.

To explore the implications of this latest approval and what it means for US surgeons and their patients, the Eye Care ...

David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...

Ophthalmic World Leaders (OWL) has unveiled its 2025 Leadership Award recipients. The honorees are recognized for driving ...

Joel S. Schuman, MD, FACS, of Wills Eye Hospital, presented an update on laser therapies for glaucoma, emphasizing recent ...

A recent Ophthalmology Times Case-Based Roundtable addressed the pathway to achieving optimized visual outcomes using an ...